Burton Mollman
Physician Assistant · Bismarck, NDNPI 1003038811
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.9% of the total across 326 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,117 and has fallen 96.7% since, to $70 in 2025. Among physician assistant clinicians in ND with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 326 payments — averaging $16.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$598
- AstraZeneca$513
- Novo Nordisk$507
- Lilly USA, LLC$490
- Astellas Pharma US Inc$408
- Boehringer Ingelheim$372
- plus $2K from 29 others
What the payments were for
- Food & beverage$5,12696%
- Education$2224%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 49 | $598 |
| AstraZeneca | 14 | $513 |
| Novo Nordisk | 32 | $507 |
| Lilly USA, LLC | 32 | $490 |
| Astellas Pharma US Inc | 18 | $408 |
| Boehringer Ingelheim | 24 | $372 |
| GSK | 17 | $234 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $199 |
| Sunovion Pharmaceuticals Inc. | 17 | $183 |
| Lundbeck LLC | 12 | $179 |
| Bayer | 10 | $171 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $165 |
| Amgen | 10 | $159 |
| Sanofi-aventis U.S. LLC | 9 | $155 |
| Johnson & Johnson | 10 | $146 |
| Pfizer | 8 | $119 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $104 |
| Merck | 7 | $102 |
| Exact Sciences | 3 | $84 |
| Daiichi Sankyo Inc. | 3 | $65 |
| Novartis | 4 | $63 |
| Eisai Inc. | 4 | $58 |
| Neurocrine Biosciences, Inc. | 2 | $38 |
| Biogen | 3 | $37 |
| Radius Health, Inc. | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 2 | $26 |
| Idorsia Pharmaceuticals US Inc | 1 | $23 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Alkermes, Inc. | 1 | $15 |
| Antares Pharma, Inc. | 1 | $14 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
| Dexcom, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,348 in reported general payments places this provider in the 95th percentile of 355 physician assistant providers in North Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 57 | $33,913 |
| OzempicSemaglutide | 25 | $25,758 |
| EliquisApixaban | 35 | $20,114 |
| KerendiaFinerenone | 24 | $16,886 |
| Aripiprazole | 19 | $5,580 |
| Rosuvastatin Calcium | 60 | $5,141 |
| Levetiracetam | 31 | $2,797 |
| Alendronate Sodium | 59 | $2,203 |
| Insulin Glargine-Yfgn | 26 | $1,975 |
| Insulin Lispro Kwikpen U-100Insulin Lispro | 19 | $1,885 |
| Pantoprazole Sodium | 26 | $1,718 |
| FenofibrateFenofibrate Nanocrystallized | 25 | $1,680 |
| Sertraline Hcl | 37 | $1,591 |
| Ropinirole Hcl | 39 | $1,463 |
| Levothyroxine Sodium | 82 | $1,351 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $372 | $33,91357 claims |
| Novo NordiskOzempic | $507 | $25,75825 claims |
| PfizerEliquis | $119 | $20,11435 claims |
| BayerKerendia | $171 | $16,88624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 355 physician assistant providers in North Dakota.
Other physician assistant in Bismarck
- Hannah SmallBismarck$10K
- Micheal HenkeBismarck$6K
- Sommer WamsleyBismarck$5K
- Brooke ArndorferBismarck$5K
- Tara Curtis HaberlockBismarck$4K
- Steele TescherBismarck$4K
- Kari ThomasBismarck$3K
- Allison TaylorBismarck$3K
- Kelsie TescherBismarck$3K
- Kari DatzBismarck$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.